Navigation Links
Large-Scale Global Registry to Examine Treatment Patterns and Disease Burden Among Patients with Venous Thromboembolism (VTE)
Date:9/3/2013

AMSTERDAM, Sept. 3, 2013 /PRNewswire/ -- The Thrombosis Research Institute (TRI) today announced the launch of the GARFIELD (Global Anticoagulant Registry in the FIELD) VTE Registry, an innovative research initiative exploring acute and long-term management and outcomes in patients with symptomatic venous thromboembolism (VTE).  Led by an international steering committee under the auspices of the TRI, the registry will follow 10,000 patients with acute VTE in a real-world setting.  GARFIELD VTE is supported by an unrestricted research grant from Bayer HealthCare.

VTE is a disease process that encompasses two interrelated conditions: deep vein thrombosis (DVT), in which a blood clot forms in a deep vein such as the legs, and pulmonary embolism (PE), a life-threatening condition in which part of the clot breaks off and is carried to the lungs through the heart, cutting off the flow of blood to the lungs.  In the Western world, one person dies every 37 seconds from VTE.

"Venous thromboembolism continues to represent an important clinical challenge, with a heavy burden for patients and healthcare systems," said Professor The Lord Kakkar, Professor of Surgery at University College London and Director of the Thrombosis Research Institute, London, UK. "Better understanding how best patient outcomes can be achieved will be greatly assisted through robust outcomes research.  We are grateful for the unrestricted grant from Bayer Healthcare to support the Garfield VTE Registry which builds on our experience in better understanding the real world challenges of providing anticoagulation to prevent thromboembolic stroke in the Garfield AF Registry."

About GARFIELD
GARFIELD is a pioneering outcomes research initiative led under the auspices of the TRI through an unrestricted research grant from Bayer HealthCare.  It is comprised of two large-scale registries: '/>"/>

SOURCE Thrombosis Research Institute
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Large-Scale Kaiser Permanente Program Linked to Improved Blood Pressure Control
2. First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams
3. First Large-Scale Population-Based Study in the U.S. Shows Hologics 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection
4. Large-Scale Meta-Analysis Shows Age Not a Social Barrier to Opioid Use and Misuse
5. BioLineRx To Present At 15th Annual Rodman & Renshaw Global Investment Conference In New York
6. DelMar Pharmaceuticals To Present At The 15th Annual Rodman & Renshaw Global Investment Conference
7. PharmAthene to Present at Rodman & Renshaw Annual Global Investment Conference
8. Peripheral Vascular Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
9. Philips launches new EPIQ premium ultrasound system with first-of-its-kind nSIGHT technology and Anatomical Intelligence, to address complicated imaging needs of an aging global population
10. MEMS in Medical Applications Market is Expected to Reach USD 6.5 Billion Globally in 2019: Transparency Market Research
11. Injectable Dose Formulations Highly Impact Global Pharmaceutical Contract Manufacturing Vendor Revenues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... Research and Markets ( http://www.researchandmarkets.com/research/32cmct/inferior_vena ) ... Cava (IVC) Filters - Global Trends, Estimates and Forecasts, ... http://photos.prnewswire.com/prnh/20130307/600769 Global Inferior Vena ... million by 2016. The North America ... value while Europe claims approximately ...
(Date:12/15/2014)... BRIDGEWATER, N.J. , Dec. 15, 2014 ... US (EURONEXT: SAN and NYSE: SNY) are collaborating with ... Cholesterol Counts , an awareness program that will ... and the risks associated with high LDL-C (bad cholesterol). ... .com to take a brief poll and answer ...
(Date:12/15/2014)... --  DaVita HealthCare Partners Inc.  (NYSE: ... most innovative health care communities, today announced that ... Research  (DCR) and  HealthCare Partners Clinical Research , will ... research and data analytics services, specifically in patients ... disease (ESRD), as well as primary care and ...
Breaking Medicine Technology:Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 2Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 3Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 2Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 3Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 5Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 6DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 3DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 4
... Incorporated (Nasdaq: VPHM ) today announced that ... of the European Medicines Agency (EMA) has adopted a ... Authorization (PUMA) for Buccolam® (midazolam, oromucosal solution), for treatment ... and adolescents, from 3 months to less than 18 ...
... serving Virginia patients reduced healthcare-acquired infection rates (HAIs) a ... of $1.2 million in additional costs to the health ... existing federal hand washing protocols, these hospitals improved patient ... patient length-of-stay and unnecessary readmissions. VHHA Services, ...
Cached Medicine Technology:ViroPharma Announces Positive CHMP Opinion for Buccolam® (Midazolam, Oromucosal Solution) in the European Union 2ViroPharma Announces Positive CHMP Opinion for Buccolam® (Midazolam, Oromucosal Solution) in the European Union 3ViroPharma Announces Positive CHMP Opinion for Buccolam® (Midazolam, Oromucosal Solution) in the European Union 4ViroPharma Announces Positive CHMP Opinion for Buccolam® (Midazolam, Oromucosal Solution) in the European Union 5Virginia Hospitals Reduce Infections 41% 2Virginia Hospitals Reduce Infections 41% 3
(Date:12/17/2014)... 17, 2014 Project Veritas is releasing ... videos of MIT economist and Obamacare architect Jonathan Gruber ... O’Keefe conducted the interview, which is being distributed on ... was intentional mislabeling in the Affordable Care Act in ... A two-hundred-and-fifty billion dollar per year tax grab. , ...
(Date:12/17/2014)... Alan Mozes HealthDay ... In the world of infectious diseases, one worrisome phenomenon is ... people. The process -- known as zoonosis -- is ... look for signs that an animal-borne disease might make inroads ... just such a development -- and the culprits in this ...
(Date:12/17/2014)... 2014 (HealthDay News) -- Poor students get more fruits and ... study finds. But, the opposite is true for students ... and vegetables at school may give a healthy boost to ... matter what the family income level, students all ate a ... found. The study was published recently in the journal ...
(Date:12/17/2014)... By Alan Mozes ... -- With the holiday party season fast approaching, a new ... and make DUI arrests have fewer drunk drivers on their ... driving laws more vigilantly are better able to deter inebriated ... "Hardly any new laws are being passed regarding drinking ...
(Date:12/17/2014)... Kathleen Doheny HealthDay Reporter ... loss is rampant in America, and work commitment is a ... No. 1 sleep killer," said Dr. Mathias Basner, an assistant ... of Pennsylvania Perelman School of Medicine. A time-use survey ... that work is the main activity exchanged for sleep. Short ...
Breaking Medicine News(10 mins):Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 3Health News:Poor Students Eat Healthier Foods at School, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3
... science at high school has just become a little more ... from the University of Bath have found that a protein ... a cell divides in two. , In research published in ... shown that the protein is essential for building the microtubules ...
... of The Walter and Eliza Hall Institute, Professor Suzanne ... of the 2008 Thomson Scientific Citation Awards announced at ... Scientific, a US-based international information analysis company, states that ... that identifies the average number of citations per paper ...
... Heart Associations Los Angeles Division today will honor John ... in use around the country and one of the ... Harbor-UCLA Medical Center (LA BioMed). , The association will ... Criley and William Koenig, Los Angeles County Emergency Medical ...
... site heralds AAGL commitment to patient education, ... professional,organization of gynecologists interested in endoscopy and minimally,invasive ... and added a,comprehensive patient education section on ... to treat them. The site,continues to provide physician ...
... ... WHITE PLAINS, N.Y., April 3, 2008 Head lice is ... common,cold.(1) There are about 6 to 12 million cases each year,(2) ... days annually.(3),But, now parents can say good-bye to head lice and ...
... April 3, 2008 Mach One,Corporation, http://www.machonecorp.com, ... prior to large scale manufacturing of its ImmunoGam(TM),colostrum ... highly qualified scientist from BioQual spent a week ... technology transfer and,memorializing the protocols for manufacture of ...
Cached Medicine News:Health News:Mitosis gets harder thanks to new gene discovery 2Health News:Professor Suzanne Cory honored with national citation award 2Health News:Pioneer of paramedic model to be honored 2Health News:Pioneer of paramedic model to be honored 3Health News:Women Can Now Learn About Minimally Invasive Gynecologic Treatments at AAGL.org 2Health News:Women Can Now Learn About Minimally Invasive Gynecologic Treatments at AAGL.org 3Health News:Women Can Now Learn About Minimally Invasive Gynecologic Treatments at AAGL.org 4Health News:New Breakthrough Treatment is Tough On Lice But Gentle On Kids 2Health News:New Breakthrough Treatment is Tough On Lice But Gentle On Kids 3Health News:Mach One Corporation Announces Completion of Final Tests Prior to Full Scale Production 2
Compression Bra...
Post-Surgical compression garments...
... The Albumin Cobalt Binding (ACB®) Test is ... Modified Albumin (IMA®) by measuring the cobalt ... serum sample. First identified in the early ... comes in contact with ischemic tissue in ...
... Test is a clinical chemistry assay that ... the cobalt binding capacity of albumin in ... the early 1990s, IMA is produced when ... tissue in the heart. During ischemia, the ...
Medicine Products: